The solution will use Owkin's data network and artificial intelligence to prescreen for gBRCA mutations in breast cancer directly from digital pathology slides.
Abionic received CE marking for the IVD Capsule PSP test in early 2017 and EU IVDR certification in mid-2022. The test is being developed for the Chinese market by Fapon under an exclusive license ...
Some results have been hidden because they may be inaccessible to you